GDF15 is overexpressed in several solid malignancies, including colorectal cancer, non–small cell lung cancer (NSCLC), urothelial carcinoma, and renal cell carcinoma (4, 6, 8, 9, 11–13). Here, GDF15 is linked to urothelial carcinoma.